Background
• Reliable calculation of effective doses of radiation therapy is a vital part of breast conserving therapy for breast cancer. [1] [2] • Multiple methods have been developed to assure reliable adjuvant targeting of the tumor bed to administer an accurate boost.
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• The BioZorb marker is a new, semi-rigid, bio-absorbable fiducial marker that contains titanium clips.
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Study Aim
• This was a prospective case series performed to evaluate the feasibility/safety of BioZorb placement in patients that would be receiving postoperative radiation therapy.
Methods
• Prospective case series of 4 general surgeons.
• BioZorb fiducial sewn into lumpectomy cavity and closed in an oncoplastic fashion. 
Results
. Radiation planning CT appearance for BioZorb Marker (A) versus titanium clip (B).
Most common patient feedback: BioZorb marker is palpable
Discussion
• Technical success of implantation of BioZorb marker is excellent.
• This case series used BioZorb in the setting of DCIS and early-stage breast cancer.
• Dramatic visual difference of BioZorb marker versus titanium clip on radiation planning CT scans.
• BioZorb fiducial does not negatively impact cosmesis. Its semi-rigid structure may actually improve cosmesis.
• Long-term patient outcomes were not evaluated.
• Low number of patients in this study (n = 12) limit study power and the conclusions that can be drawn.
Conclusions
• BioZorb marker is easy to place, well-tolerated, and safe.
• Consideration should be made to place a BioZorb marker in patients in whom postoperative radiation is planned.
Future Directions
• Evaluate long-term patient outcomes.
• Satisfaction survey for radiation oncologists.
